February 26, 2024
On behalf of the TeamHealth Emerging Infectious Disease Task Force Respiratory viruses – primarily COVID-19, Influenza, and RSV are having an impact as winter conditions enhance communicability. Elevated numbers of cases and admissions for all three of these viruses were reported at the beginning of this year. The severity of the clinical impacts varies…
December 20, 2023
On behalf of the TeamHealth Emerging Infectious Disease Task Force Some antiviral medications have demonstrated efficacy against the SARS-CoV-2 virus. Often this efficacy is limited to the laboratory, specific populations or viral variants. However, Paxlovid has demonstrated high effectiveness in certain high-risk populations and is the most commonly used antiviral agent in the United States…
August 17, 2023
By David E. Hogan, DO, MPH, FACEP Vice President of Educational Development TeamHealth Chair TeamHealth Emerging Infectious Disease Taskforce Despite all our medical prowess, nothing has improved health and well-being more than public health. And little in public health has impacted this more than vaccines. There are 25 safe and effective vaccines against dangerous pathogens…
May 5, 2023
While COVID-19 affects multiple organ systems, many studies have notably identified adverse and persistent pulmonary issues, particularly in patients with severe acute cases. Much of this pulmonary injury is detectable long after recovery from COVID-19. Pulmonary Pathophysiology and Long COVID There is risk of COVID-19-causing irreversible pulmonary damage during the acute phase of COVID-19. Continued…
March 6, 2023
In part four of the Long COVID series, TeamHealth’s Emerging Infectious Disease Taskforce (EIDT) addresses the major cardiovascular issues reported. Despite the recent development of Long COVID, researchers are gaining a better perspective on related cardiovascular problems. COVID-19 and the Cardiovascular System Cardiovascular complications have been well-known since the onset of the pandemic. The EIDT…
December 7, 2022
During the pandemic, the SARS-Co-V-2 virus has been associated with a number of acute neurological problems. Because of this, it should be no surprise that lasting outcomes have also been identified as part of Long COVID. In this segment, we will briefly cover some of the most commonly reported neurologic issues associated with the nervous…
December 1, 2022
The term “Long COVID” is one of many terms with variable definitions. As with many emerging disease processes, the terms used have evolved along with our perspectives and understanding of the disease. Long COVID and other associated terms currently serve as more of an umbrella moniker for a wide range of physical and mental health…